Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Porcine Butyrylcholinesterase (BCHE) ELISA Kit-Sandwich

Name: Porcine Butyrylcholinesterase (BCHE) ELISA Kit-Sandwich
SKU: EK10F5
Rating: 5 (1 reviews)

Cat. No.EK10F5

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Inquiry List

Product Overview

BioVenic Porcine BCHE ELISA Kit-Sandwich is designed for the quantitative determination of Porcine butyrylcholinesterase (BCHE) in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Porcine BCHE.

Target Species Swine

Species Reactivity Swine

Detection Range 0.35-20 ng/mL

Sensitivity 0.06 ng/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

Butyrylcholinesterase is encoded by the BCHE gene in pigs. It has been identified as one of the most likely targets of curcumin which has a potential pharmacological value.

Target/Biomarker Porcine BCHE

Target Synonym butyrylcholinesterase; cholinesterase; Acylcholine acylhydrolase; Butyrylcholine esterase; Choline esterase II; Pseudocholinesterase; butylcholinesterase

Gene ID 100624138

UniProt ID P32752

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Wang, X. et al. Prediction and verification of curcumin as a potential drug for inhibition of PDCoV replication in LLC-PK1 cells. International journal of molecular sciences. 2023, 24: 5870.